Clinical Trial Update: Pharmacokinetics of SSP-004184 in the Treatment of Chronic Iron Overload Requiring Chelation Therapy [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetics study of SSP-004184 for iron overload due to chronic transfusion-dependent conditions was terminated with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Overload

Drugs mentioned

• SSP-004184

Snippet

Sponsor: Shire | Conditions: Iron Overload Due to Repeated Red Blood Cell Transfusions | Phase 2 | Status: TERMINATED | Results posted: 2015-08-17